US President Donald Trump mentioned the possibility of potential tariffs on foreign-made pharmaceuticals. This threat was ...

MSD has begun construction on a $1bn biologics centre of excellence, Merck Wilmington Biotech, in the US state of Delaware.

While the pharmaceutical industry is currently exempt from US tariffs, there is an increased risk to the stability of the ...

Funding troubles and innovation responsibilities are falling more heavily on emerging biotechs under strain from US ...

CEO Soriot said Europe must boost investment in pharma innovation or risk falling further behind the US in drug development.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for BridgeBio Pharma’s ...

Biotech Biohaven has signed a non-dilutive funding deal with Oberland Capital as it awaits an FDA ruling on its ...

Prilenia has signed a partnership and licence agreement with Ferrer for jointly developing and commercialising pridopidine in ...

The EC has granted conditional marketing approval to Regeneron Pharmaceuticals’ bispecific antibody Lynozyfic for treating ...

Merck has moved to strengthen its position in oncology and rare diseases with a $3.9bn agreement to acquire SpringWorks ...

The EC has granted marketing authorisation for Johnson & Johnson's (J&J) Tremfya to treat adults with ulcerative colitis (UC) ...

French health authorities have suspended the use of Valneva’s chikungunya vaccine Ixchiq in adults aged 65 and older after ...